Hedge fund manager Kyle Bass and his Coalition for Affordable Drugs are continuing their campaign against certain pharmaceutical patents, most recently seeking to invalidate patents owned by Celgene and NPS Pharma.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Kyle Bass, Coalition for Affordable Drugs, Celgene, NPS Pharma, inter partes review